New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association. In the US, ...
The national five-year survival rate for lung cancer has climbed to nearly 30%, up from 18% from eight years ago, according to the American Lung Association.
November is Lung Cancer Awareness Month, which is the leading cause of cancer-related deaths among both men and women.
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
According to the NCCN Guidelines for metastatic lung cancer, standard therapies remain valuable, but they are no longer sufficient on their own. This is why molecular profiling, targeted therapy, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results